Results of patch testing 2‐hydroxyethyl methacrylate ( HEMA ) in the European baseline series: A 4‐year retrospective study
Contact Dermatitis · 2024
DOI: 10.1111/cod.14488 ↗At a glance
Journal article in Contact Dermatitis, 2024. Written by Gizem Kocabas and 3 co-authors. Institution: Amsterdam University Medical Centers, Amsterdam, The Netherlands. Major MEDLINE topics: Dermatitis, Allergic Contact, Cosmetics, Dermatitis, Occupational. Cited 12 times so far (Crossref); 21 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background
2‐Hydroxyethyl methacrylate (HEMA) was added to the European baseline series (EBS) in 2019. Few recent data are available on the frequency and relevance of positive reactions to this hapten.
Objectives
To investigate the frequency and relevance of positive patch tests to HEMA in the EBS in a university hospital in Amsterdam, The Netherlands. Patients and Methods Retrospective study in patients with positive patch tests to HEMA investigated between June 2019 and August 2023.
Results
Of 2927 consecutive patients, 88 (79 women and 9 men; 3.0%) had a positive reaction to HEMA. The prevalence in women was 3.9%, in men 1.0%. Forty‐three (49%) reactions were judged to be of current clinical relevance and 21 (24%) of past relevance. In this group of 64 patients with relevant reactions, 18 (28%) had occupational contact with (meth)acrylate‐containing products, of who 11 (61%) were nail stylists. In 46 patients with non‐occupational allergic contact dermatitis, 31 (67%) had allergic reactions to nail cosmetics. Glues and glue‐containing products accounted for 22% of the materials causing allergic contact dermatitis and dental products for 8%.
Conclusions
Allergic reactions to HEMA are very frequent in women investigated in Amsterdam. Nearly two thirds of cases were caused by nail cosmetics.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Amsterdam University Medical Centers, Amsterdam, The Netherlands.
- Dermato-Allergology and Occupational Dermatology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
ORCID profiles: Anton de Groot, Thomas Rustemeyer
Cite
APA
Kocabas, G., Steunebrink, I. M., de Groot, A., & Rustemeyer, T. (2024). Results of patch testing 2‐hydroxyethyl methacrylate ( HEMA ) in the European baseline series: A 4‐year retrospective study. Contact Dermatitis. https://doi.org/10.1111/cod.14488
Vancouver
Kocabas G, Steunebrink IM, de Groot A, Rustemeyer T. Results of patch testing 2‐hydroxyethyl methacrylate ( HEMA ) in the European baseline series: A 4‐year retrospective study. Contact Dermatitis. 2024. doi:10.1111/cod.14488
BibTeX
@article{Kocabas2024,
author = {Kocabas, Gizem and Steunebrink, Iemke M and de Groot, Anton and Rustemeyer, Thomas},
title = {Results of patch testing 2‐hydroxyethyl methacrylate ( HEMA ) in the European baseline series: A 4‐year retrospective study},
journal = {Contact Dermatitis},
year = {2024},
doi = {10.1111/cod.14488}
}
EUVIMED